Most Read News

Gujarat Urja Vikas Nigam Ltd (GUVNL) has selected the company for handling part of a 500 MW/1000 MWh standalone battery energy storage initiative.

Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.

The legal proceedings resulted with the notice being removed. SECI does not have the authority to take any legal action in light of this withdrawal.

ExxonMobil and other international oil companies have been calling for a clause allowing arbitration outside of India to settle disputes.

Indoco Remedies will also continue providing products to its existing B2B customers under existing deals.

Larsen & Toubro agreed to buy a 21% share in E2E Networks Ltd, a cloud services company, for ₹1,407.02 Crore.

HDFC Life, HDFC Bank, Apollo Hospital, and NTPC are the major gainers in Nifty. Conversely, Cipla, Bharti Airtel, PowerGrid Corp, and Tata Motors top the list of losers in Nifty.

On December 4, the indices closed higher amid high volatility.

Vodafone will clear its $101 million debt (about ₹856 Crore) and utilize the remaining cash to cover its Indian venture.

Arcedo Systems will undertake the design, engineering, installation, and ongoing maintenance of the solar power facility.